MacroGenics (MGNX) Short Interest Ratio & Short Volume → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free MGNX Stock Alerts $4.36 -0.75 (-14.66%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability MacroGenics Short Interest DataCurrent Short Volume9,960,000 sharesPrevious Short Volume8,600,000 sharesChange Vs. Previous Month+15.81%Dollar Volume Sold Short$147.21 millionShort Interest Ratio / Days to Cover6.9Last Record DateApril 30, 2024Outstanding Shares62,630,000 sharesFloat Size58,520,000 sharesShort Percent of Float17.02%Today's Trading Volume3,865,995 sharesAverage Trading Volume4,198,301 sharesToday's Volume Vs. Average92% Short Selling MacroGenics ? Sign up to receive the latest short interest report for MacroGenics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMGNX Short Interest Over TimeMGNX Days to Cover Over TimeMGNX Percentage of Float Shorted Over Time Ad InvestorPlaceBible Shocker: Have You Seen Elon Musk’s Miracle?Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… MacroGenics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,960,000 shares $147.21 million +15.8%17.0%6.9 $14.78 4/15/20248,600,000 shares $145.68 million +33.3%14.7%5.6 $16.94 3/31/20246,450,000 shares $94.94 million +15.2%11.0%4.1 $14.72 3/15/20245,600,000 shares $89.21 million +11.6%9.6%4.2 $15.93 2/29/20245,020,000 shares $90.06 million -21.3%8.6%4.2 $17.94 2/15/20246,380,000 shares $111.01 million -23.5%11.0%6.8 $17.40 Get the Latest News and Ratings for MGNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MacroGenics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20248,340,000 shares $119.26 million +5.2%14.2%9.3 $14.30 1/15/20247,930,000 shares $84.85 million +2.6%13.5%10.7 $10.70 12/31/20237,730,000 shares $74.36 million +7.2%13.2%12.1 $9.62 12/15/20237,210,000 shares $66.76 million +13.5%12.3%10.9 $9.26 11/30/20236,350,000 shares $52.13 million -1.4%10.9%10.7 $8.21 11/15/20236,440,000 shares $46.82 million -4.7%11.0%11 $7.27 10/31/20236,760,000 shares $35.29 million +9.0%11.6%11.1 $5.22 10/15/20236,200,000 shares $31.43 million +26.3%10.6%10.9 $5.07 9/30/20234,910,000 shares $22.88 million -6.3%8.4%9.7 $4.66 9/15/20235,240,000 shares $24.42 million +5.9%9.0%10 $4.66 8/31/20234,950,000 shares $23.07 million -1.2%8.5%9 $4.66 8/15/20235,010,000 shares $26.85 million -10.5%8.6%8.8 $5.36 7/31/20235,600,000 shares $26.71 million -2.1%9.6%11.3 $4.77 7/15/20235,720,000 shares $28.14 million -4.0%9.8%11.7 $4.92 6/30/20235,960,000 shares $31.89 million +40.2%10.2%11.8 $5.35 6/15/20234,250,000 shares $25.54 million -7.0%7.3%8.7 $6.01 5/31/20234,570,000 shares $21.34 million -4.2%7.8%8.6 $4.67 5/15/20234,770,000 shares $31.10 million +1.1%8.2%9 $6.52 4/30/20234,720,000 shares $32.52 million -3.1%N/A7.5 $6.89 4/15/20234,870,000 shares $31.61 million +4.7%N/A7.6 $6.49 3/31/20234,650,000 shares $33.34 million -0.6%N/A6.8 $7.17 3/15/20234,680,000 shares $29.67 million +5.6%N/A6.8 $6.34 2/28/20234,430,000 shares $26.98 million -1.6%7.4%7 $6.09 2/15/20234,500,000 shares $21.69 million -2.2%7.5%6 $4.82 1/31/20234,600,000 shares $26.54 million +5.3%7.7%6.1 $5.77 1/15/20234,370,000 shares $23.12 million +5.3%7.4%5.1 $5.29 12/30/20224,150,000 shares $27.85 million +7.8%7.0%4.5 $6.71 12/15/20223,850,000 shares $23.75 million -5.6%6.5%4.2 $6.17 11/30/20224,080,000 shares $26.23 million -4.5%6.9%4.4 $6.43 11/15/20224,270,000 shares $28.31 million -15.8%7.2%4.8 $6.63 10/31/20225,070,000 shares $25.96 million +2.6%8.5%6.2 $5.12 10/15/20224,940,000 shares $17.39 million -0.4%8.3%6.4 $3.52 9/30/20224,960,000 shares $17.16 million +1.9%8.3%5.9 $3.46 9/15/20224,870,000 shares $17.24 million -0.8%8.2%5.3 $3.54CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. MGNX Short Interest - Frequently Asked Questions What is MacroGenics' current short interest? Short interest is the volume of MacroGenics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 9,960,000 shares of MGNX short. 17.02% of MacroGenics' shares are currently sold short. Learn More on MacroGenics' current short interest. What is a good short interest ratio for MacroGenics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MGNX shares currently have a short interest ratio of 7.0. Learn More on MacroGenics's short interest ratio. Which institutional investors are shorting MacroGenics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of MacroGenics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for MacroGenics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.02% of MacroGenics' floating shares are currently sold short. Is MacroGenics' short interest increasing or decreasing? MacroGenics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 9,960,000 shares, an increase of 15.8% from the previous total of 8,600,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MacroGenics' float size? MacroGenics currently has issued a total of 62,633,000 shares. Some of MacroGenics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MacroGenics currently has a public float of 58,520,000 shares. How does MacroGenics' short interest compare to its competitors? 17.02% of MacroGenics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to MacroGenics: Xeris Biopharma Holdings, Inc. (6.50%), Enanta Pharmaceuticals, Inc. (14.15%), Inozyme Pharma, Inc. (8.23%), Neoleukin Therapeutics, Inc. (0.35%), XBiotech Inc. (3.88%), Emergent BioSolutions Inc. (14.13%), Aquestive Therapeutics, Inc. (5.79%), Rani Therapeutics Holdings, Inc. (10.88%), ESSA Pharma Inc. (2.09%), CorMedix Inc. (17.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short MacroGenics stock? Short selling MGNX is an investing strategy that aims to generate trading profit from MacroGenics as its price is falling. MGNX shares are trading down $0.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MacroGenics? A short squeeze for MacroGenics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MGNX, which in turn drives the price of the stock up even further. How often is MacroGenics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MGNX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: XERS Short Squeeze ENTA Short Squeeze INZY Short Squeeze NLTX Short Squeeze XBIT Short Squeeze EBS Short Squeeze AQST Short Squeeze RANI Short Squeeze EPIX Short Squeeze CRMD Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MGNX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research